Merck Tbk. vs Tunas Baru Lampung Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Tunas Baru Lampung Tbk. trades at Rp640 (market cap 3.83T, 715.7K 24h volume). The key difference: Tunas Baru Lampung Tbk. is far larger — about 2.3× Merck Tbk.'s market cap, and Tunas Baru Lampung Tbk. is more actively traded (715.7K versus 37.6K). Which is the better fit depends on your goals.
| MERK | TBLA | |
|---|---|---|
Market Cap | 1.7T | 3.83T |
Volume | 37.6K | 715.7K |
Lot | 376 | 7.16K |
Turnover | 144.47M | 456.89M |
Average Price | 3,842.23 | 638.39 |
Value | 144.47M | 456.89M |
Indicative Equilibrium Price | 3,840 | 640 |
Indicative Equilibrium Volume | 7 | 56 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Tunas Baru Lampung Tbk (the Company) was established by virtue of Notarial Deed No. 23 dated December 22, 1973 of Halim Kurniawan, S.H., public notary in Teluk Betung. PT. Tunas Baru Lampung is a member of Sungai Budi Group which was founded in 1947 and is a pioneer in Indonesia`s agricultural industry.
Read more on TBLA →